MediWound Ltd.
MDWDNASDAQHealthcare● Active
$14.21
+$0.03(+0.21%)
Market Cap$154355841
P/E Ratio—
52W High$22.09
52W Low$13.54
MediWound Ltd. (MDWD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDWD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 27, 2026EPS Actual
-$0.23
Est. -$0.65 · +64.6%
Revenue
$0.00B
Est. $0.00B · -56.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 27, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 3-Quarter EPS Beat Streak
MDWD reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.76 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 27, 2026 | -$0.65 | -$0.23 | +64.6% | $0.00B | $0.00B | -56.2% |
| ▲ Q1 FY2026 | Mar 5, 2026 | -$0.65 | -$0.56 | +13.8% | $0.00B | $0.00B | -55.5% |
| ▲ Q4 FY2025 | Nov 20, 2025 | -$0.81 | -$0.24 | +70.4% | $0.01B | $0.00B | +160.1% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.55 | -$1.23 | -123.6% | $0.01B | $0.01B | -13.0% |
| ▲ Q2 FY2025 | May 21, 2025 | -$0.65 | -$0.07 | +89.2% | $0.00B | $0.01B | -31.4% |
| ▲ Q1 FY2025 | Mar 19, 2025 | -$0.59 | -$0.36 | +39.0% | $0.01B | $0.01B | +11.1% |
| ▼ Q4 FY2024 | Nov 26, 2024 | -$0.44 | -$0.98 | -122.7% | $0.00B | $0.01B | -25.3% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.76
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 27, 2026Beat
EPS Actual
-$0.23
EPS Est.
-$0.65
EPS Surpr.
+64.6%
Revenue
$0.00B
Q1 FY2026
Mar 5, 2026Beat
EPS Actual
-$0.56
EPS Est.
-$0.65
EPS Surpr.
+13.8%
Revenue
$0.00B
Q4 FY2025
Nov 20, 2025Beat
EPS Actual
-$0.24
EPS Est.
-$0.81
EPS Surpr.
+70.4%
Revenue
$0.01B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$1.23
EPS Est.
-$0.55
EPS Surpr.
-123.6%
Revenue
$0.01B
Q2 FY2025
May 21, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.65
EPS Surpr.
+89.2%
Revenue
$0.00B
Q1 FY2025
Mar 19, 2025Beat
EPS Actual
-$0.36
EPS Est.
-$0.59
EPS Surpr.
+39.0%
Revenue
$0.01B
Q4 FY2024
Nov 26, 2024Miss
EPS Actual
-$0.98
EPS Est.
-$0.44
EPS Surpr.
-122.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 2 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 2 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 2 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 2 |
| Q4 FY2027 | $-0.58 | $-0.48 | $-0.37 | 1 |
| Q3 FY2027 | $-0.63 | $-0.53 | $-0.40 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 27, 2026 | +64.6% | $16.68 | $14.33 | -14.09% |
| ▲ Q1 FY2026 | Mar 5, 2026 | +13.8% | $17.60 | $17.45 | -0.85% |
| ▲ Q4 FY2025 | Nov 20, 2025 | +70.4% | $17.86 | $16.86 | -5.60% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -123.6% | $18.75 | $18.57 | -0.96% |
| ▲ Q2 FY2025 | May 21, 2025 | +89.2% | $20.87 | $19.89 | -4.70% |
| ▲ Q1 FY2025 | Mar 19, 2025 | +39.0% | $19.27 | $18.28 | -5.14% |
| ▼ Q4 FY2024 | Nov 26, 2024 | -122.7% | $17.33 | $16.90 | -2.48% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -61.9% | $18.21 | $17.47 | -4.06% |
Q2 FY2026-14.09%
Report Date
May 27, 2026
EPS Beat/Miss
+64.6%
Price Before
$16.68
Price After
$14.33
Q1 FY2026-0.85%
Report Date
Mar 5, 2026
EPS Beat/Miss
+13.8%
Price Before
$17.60
Price After
$17.45
Q4 FY2025-5.60%
Report Date
Nov 20, 2025
EPS Beat/Miss
+70.4%
Price Before
$17.86
Price After
$16.86
Q3 FY2025-0.96%
Report Date
Aug 14, 2025
EPS Beat/Miss
-123.6%
Price Before
$18.75
Price After
$18.57
Q2 FY2025-4.70%
Report Date
May 21, 2025
EPS Beat/Miss
+89.2%
Price Before
$20.87
Price After
$19.89
Q1 FY2025-5.14%
Report Date
Mar 19, 2025
EPS Beat/Miss
+39.0%
Price Before
$19.27
Price After
$18.28
Q4 FY2024-2.48%
Report Date
Nov 26, 2024
EPS Beat/Miss
-122.7%
Price Before
$17.33
Price After
$16.90
Q3 FY2024-4.06%
Report Date
Aug 14, 2024
EPS Beat/Miss
-61.9%
Price Before
$18.21
Price After
$17.47
Avg Beat Reaction-6.08%
Avg Miss Reaction-2.50%
Beat Rate5 / 8 quarters
Largest Move-14.09% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDWD ends December
MediWound Ltd. (MDWD) most recently reported earnings on May 27, 2026 for Q2 FY2026, posting EPS of $-0.23 — beating the analyst consensus of $-0.65 by +64.6%. MDWD has beaten EPS estimates for 3 consecutive quarters. The next MDWD earnings date is expected around September 1, 2026.
Each quarter, investors track MDWD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDWD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDWD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDWD earnings · 5 questionsMediWound Ltd.'s next earnings report is expected around September 1, 2026. MDWD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDWD historically reports after market close (AMC).
MDWD earnings datewhen is MDWD earningsMDWD next earnings datewhen does MDWD report earningsMDWD earnings calendar
▸ Source: FMP · MediWound Ltd. SEC filings · US GAAP · MediWound Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026